-+ 0.00%
-+ 0.00%
-+ 0.00%

According to the Zhitong Finance App, Baiyunshan (600332.SH) announced that Guangzhou Pharmaceutical, a holding subsidiary of the company, plans to transfer 100% of the shares of Haizheng Pharmaceutical Co., Ltd. (“Zhejiang Medical”) through public delisting, with a transfer price of 501 million yuan.

Zhitongcaijing·12/17/2025 11:33:09
Listen to the news
According to the Zhitong Finance App, Baiyunshan (600332.SH) announced that Guangzhou Pharmaceutical, a holding subsidiary of the company, plans to transfer 100% of the shares of Haizheng Pharmaceutical Co., Ltd. (“Zhejiang Medical”) through public delisting, with a transfer price of 501 million yuan.